Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

81
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
81
Lipid-derived Compounds in the Human Body01:31

Lipid-derived Compounds in the Human Body

4.4K
Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various  biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
4.4K
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

802
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
802
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

731
Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
731

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

[Bempedoic acid in real-world clinical practice: baseline and 8-week data from the Italian prospective, non-interventional MILOS study].

Giornale italiano di cardiologia (2006)·2026
Same author

[Fish Oil for the Heart? The Role of Omega-3 Fatty Acids in Cardiovascular Medicine].

MMW Fortschritte der Medizin·2026
Same author

MMW Fortschritte der Medizin·2026
Same author

Lipid Therapy in Patients with Diabetes Mellitus.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association·2026
Same author

Association of the C-reactive protein-triglyceride glucose index with all-cause and cardiovascular mortality among U.S. adults with metabolic dysfunction-associated steatotic liver disease: a national cohort study.

Cardiovascular diabetology·2026
Same author

MMW Fortschritte der Medizin·2026

相关实验视频

Updated: Jun 29, 2025

Enzymatic Synthesis of Epoxidized Metabolites of Docosahexaenoic, Eicosapentaenoic, and Arachidonic Acids
13:05

Enzymatic Synthesis of Epoxidized Metabolites of Docosahexaenoic, Eicosapentaenoic, and Arachidonic Acids

Published on: June 28, 2019

8.0K

在降低心血管风险方面区分EPA和EPA/DHA.

Peter P Toth1,2, M John Chapman3, Klaus G Parhofer4

  • 1CGH Medical Center, Sterling, IL, USA.

American heart journal plus : cardiology research and practice
|April 1, 2024
PubMed
概括

在REDUCE-IT试验中,高剂量的纯化乙酸 (EPA) 显著降低了心血管事件和死亡率,与其他omega-3脂肪酸组合不同. 这突出了EPA的重点.

关键词:
心血管疾病的心血管疾病.达科萨赫克萨埃诺酸是什么?埃可萨丁烯酸是什么 埃可萨丁烯酸是什么伊科萨特乙烯的使用情况欧米茄-3脂肪酸的使用方法三甲酸甘油三甲酸甘油是什么

更多相关视频

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

8.3K
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.6K

相关实验视频

Last Updated: Jun 29, 2025

Enzymatic Synthesis of Epoxidized Metabolites of Docosahexaenoic, Eicosapentaenoic, and Arachidonic Acids
13:05

Enzymatic Synthesis of Epoxidized Metabolites of Docosahexaenoic, Eicosapentaenoic, and Arachidonic Acids

Published on: June 28, 2019

8.0K
Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

8.3K
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.6K

科学领域:

  • 心脏病学 心脏病学
  • 药理学 药理学是指药理学的学科.
  • 生物化学 生物化学

背景情况:

  • 之前使用结合的eicosapentaenoic acid (EPA) 和docosahexaenoic acid (DHA) 的试验未能证明心血管益处,尽管降低了甘油三.
  • EPA与DHA的独特药理学表明它们对炎症和细胞过程的作用机制不同.

研究的目的:

  • 评估高剂量净化EPA在降低风险患者心血管事件中的有效性.
  • 在接受他类药物治疗的患者中,比较纯化EPA与安慰剂的心血管结果.

主要方法:

  • 减少心血管事件与Icosapent乙烯干预试验 (REDUCE-IT) 管理高剂量 (4克/天) 净化EPA.
  • 参与者接受了EPA作为对他类药物治疗的辅助疗法.
  • 心血管结果,包括主要心血管不良事件和死亡率,在EPA和安慰剂组之间进行了比较.

主要成果:

  • 高剂量的纯化EPA显示,动脉样硬化心血管疾病相关事件减少了25% (HR 0.75;P < 0.001).
  • REDUCE-IT显示了心血管死亡率的显著降低,这是降脂剂作为辅助性他类药物治疗的首次.
  • 观察到,中风,心肌梗塞和需要重血管化的情况显著减少.

结论:

  • 高剂量纯化EPA在减少特定患者群体的心血管事件和死亡率方面是有效的,特别是在与他类药物一起使用时.
  • 达到血EPA水平,可能超过100μg/mL,可能对实现临床益处至关重要.
  • 这些发现证实了EPA疗法在降低心血管疾病风险方面的有效性,与EPA和DHA组合配方不同.